MSB 5.24% $1.11 mesoblast limited

Well we don't know it will do no harm as we don't have...

  1. 6,428 Posts.
    lightbulb Created with Sketch. 2617
    Well we don't know it will do no harm as we don't have validated, well controlled RCTs for that age group or other age groups. It has been rejected by FDA twice. So I'm not sure your advice would be consistent with your position.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.